About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

Respiratory infections, including mycoplasma pneumoniae, continue to affect children in Chennai, prompting doctors to ...

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial ...